Literature DB >> 6057823

Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment.

P H Sönksen, F C Greenwood, J P Ellis, C Lowy, A Rutherford, J D Nabarro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6057823     DOI： 10.1210/jcem-27-10-1418

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  37 in total

1.  Hormonal interrelations and their clinical significance. Growth hormone and insulin.

Authors:  P H Sönksen
Journal:  Proc R Soc Med       Date:  1975-11

2.  Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly.

Authors:  E Lin; T L Wexler; L Nachtigall; N Tritos; B Swearingen; L Hemphill; J Loeffler; B M K Biller; A Klibanski; K K Miller
Journal:  Clin Endocrinol (Oxf)       Date:  2012-09       Impact factor: 3.478

3.  Diabetes mellitus after hypophysectomy for acromegaly.

Authors:  V A Fonseca; P Dandona; C W Havard
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

4.  Growth hormone secretion in diabetic children.

Authors:  E Otto-Buczkowska; F Kobot; J Kuska
Journal:  Z Kinderheilkd       Date:  1974

5.  Analogue analysis of oral glucose tolerance test and insulin secretion in acromegaly.

Authors:  C Scandellari; D Casara; M Zaccaria; G Sirotich; E Zago; N Sicolo; G Federspil
Journal:  Acta Diabetol Lat       Date:  1974 Jan-Feb

6.  Abnormal serum growth hormone responses in genetically potential-diabetic male patients with normal oral glucose tolerance: evidence for an insulin-like action of growth hormone in vivo.

Authors:  P H Sönksen; J S Soeldner; R E Gleason; G Boden
Journal:  Diabetologia       Date:  1973-10       Impact factor: 10.122

7.  Primary hyperparathyroidism is associated with decreased insulin receptor binding and glucose intolerance.

Authors:  R Prager; G Schernthaner; J Kovarik; G Cichini; K Klaushofer; R Willvonseder
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

8.  Skeletal muscle glucose transporter gene expression is not affected by injecting growth-hormone-secreting cells in young rats.

Authors:  H Imamura; I Morimoto; S Etoh; T Usa; H Namba; A Ohtsuru; A Yokota; S Nagataki; S Yamashita
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

9.  Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.

Authors:  M A Hussain; O Schmitz; A Mengel; A Keller; J S Christiansen; J Zapf; E R Froesch
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Therapeutic options in the management of acromegaly: focus on lanreotide Autogel.

Authors:  Ferdinand Roelfsema; Nienke R Biermasz; Alberto M Pereira; Johannes A Romijn
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.